Labcorp Holdings Inc LH
News
Labcorp to Speak at the UBS Global Healthcare Conference
The big winners of the tech wreck are biopharma stocks
Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance
Waters and Labcorp to Expand Access to Cervical Cancer Screening with the Most Comprehensive FDA-Approved HPV Testing Option Beginning in Late 2026
Labcorp, Charles River and FDA Announce Research Collaboration to Advance Preclinical Methods for Evaluating Drug Abuse Potential
Labcorp Declares Quarterly Dividend
Myriad Genetics and Labcorp Announce Definitive Agreement for Myriad to Sell Prenatal Health Testing Business to Labcorp
Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health
Labcorp and Arianna Huffington's Thrive Global Collaborate to Launch Thrive 5 Health Test
Labcorp to Announce Third Quarter 2026 Financial Results on October 28, 2026
Diagnostic-Testing Stocks Slide After Proposed Cuts to Medicare Payments for Lab Services
Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day
Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update
Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials
Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity
Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference
FDA Approves Alzheimer's Blood Test Developed by Roche and Eli Lilly
Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings
The latest Oura and Fitbit wearables are smarter and sleeker than ever - but do they keep you healthy?



